Evidence map›Paper›PMID 39183335›Full record

ArticleNature communications2024

Asymmetric N-oxidation catalyzed by bisguanidinium dinuclear oxodiperoxomolybdosulfate.

Wentao Wu, Esther Cai Xia Ang, Xinru Xu, Qi Wang, Hong Wang, Richmond Lee, Choon-Hong Tan, Xinyi Ye

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wentao WuCollege of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, P. R. China.
Esther Cai Xia AngSchool of chemistry, Chemical Engineering and Biotechnology, 21 Nanyang Link, Singapore 637371, Nanyang Technological University, Singapore, Singapore.
Xinru XuCollege of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, P. R. China.
Qi WangCollege of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, P. R. China.
Hong WangCollege of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, P. R. China. hongw@zjut.edu.cn.
Richmond LeeSchool of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW, Australia. richmond_lee@uow.edu.au.ORCID http://orcid.org/0000-0003-1264-4914
Choon-Hong TanSchool of chemistry, Chemical Engineering and Biotechnology, 21 Nanyang Link, Singapore 637371, Nanyang Technological University, Singapore, Singapore. choonhong@ntu.edu.sg.ORCID http://orcid.org/0000-0003-3190-7855
Xinyi YeCollege of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, P. R. China. xinyiye1020@zjut.edu.cn.ORCID http://orcid.org/0000-0002-5344-9122

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22101255
6 · The paper itself

Abstract

N-oxides play a pivotal role in natural products and emerging drug design, while also serving as valuable ligand scaffolds in organometallic chemistry. Among heteroatom oxidations, the conversion of amines to N-oxides is a critical and challenging facet. We present here a highly enantioselective N-oxidation methodology for both cyclic and acyclic amines. The method employs an ion-pair catalyst comprising a chiral bisguanidinium [BG]

Identifiers

PMID39183335
PMCPMC11345438

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.